SESSION TITLE: Impact of Pleural Disorders
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Monday, October 24, 2016 at 07:30 AM - 08:30 AM
PURPOSE: Symptomatic benign refractory or recurrent pleural effusions represent a complex clinical conundrum due to limited therapeutic options. Indwelling pleural catheter (IPC), which was initially introduced for the management of recurrent malignant effusions could be a valuable management option for recurrent benign pleural effusions (BPE), in place of chemical pleurodesis.. IPC placement may not be permanent as it can result in pleurodesis and it can be removed subsequently. IPC placement for BPE is supported by small clinical trails and reports and large randomized clinical trials are lacking. The purpose of this study is to analyze the efficacy and safety of IPC in the management of refractory non-malignant effusions.